Mark W Konijnenberg (Mark Konijnenberg)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Randomized Controlled Trial

Computed Tomography

Liver Metastases

Top Venues

Pharmacology research & perspectives

European journal of nuclear medicine and molecular imaging

EJNMMI research

This page only lists publications with an associated author ORCID identifier.

Publications

Kevin R Doornhof, Quido G de Lussanet de la Sablonière, Stijn L W Koolen, Mark W Konijnenberg
Treatment of [99mTc]Tc-hydroxy-diphosphonate ([99mTc]Tc-HDP) extravasation using hyaluronidase. Pharmacology research & perspectives 12 (4) (2024)
Kevin R Doornhof, Quido G de Lussanet de la Sablonière, Stijn L W Koolen, Mark W Konijnenberg
Treatment of [99mTc]Tc-hydroxy-diphosphonate ([99mTc]Tc-HDP) extravasation using hyaluronidase. Pharmacology research & perspectives 12 (4) (2024)
Kevin R Doornhof, Quido G de Lussanet de la Sablonière, Stijn L W Koolen, Mark W Konijnenberg
Treatment of [99mTc]Tc-hydroxy-diphosphonate ([99mTc]Tc-HDP) extravasation using hyaluronidase. Pharmacology research & perspectives 12 (4) (2024)
Julie C Refardt, Maria J Klomp, Peter M van Koetsveld, Fadime Dogan, Mark W Konijnenberg, Tessa Brabander, Richard A Feelders, Wouter W de Herder, Leo J Hofland, Johannes Hofland
Effect of epigenetic treatment on SST 2 expression in neuroendocrine tumour patients. Clinical and translational medicine 12 (7) (2022)
Simone C Kleinendorst, Egbert Oosterwijk, Johan Bussink, Harm Westdorp, Mark W Konijnenberg, Sandra Heskamp
Combining Targeted Radionuclide Therapy and Immune Checkpoint Inhibition for Cancer Treatment. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (17) (2022)
Joey Roosen, Lovisa E L Westlund Gotby, Mark J Arntz, Jurgen J Fütterer, Marcel J R Janssen, Mark W Konijnenberg, Meike W M van Wijk, Christiaan G Overduin, Johannes Frank Wilhelmus Nijsen
Intraprocedural MRI-based dosimetry during transarterial radioembolization of liver tumours with holmium-166 microspheres (EMERITUS-1): a phase I trial towards adaptive, image-controlled treatment delivery. European journal of nuclear medicine and molecular imaging 49 (13) (2022)
Yongsheng Liu, Anzhelika Vorobyeva, Anna Orlova, Mark W Konijnenberg, Tianqi Xu, Olga Bragina, Annika Loftenius, Erica Rosander, Fredrik Y Frejd, Vladimir Tolmachev
Experimental Therapy of HER2-Expressing Xenografts Using the Second-Generation HER2-Targeting Affibody Molecule 188 Re-ZHER2:41071. Pharmaceutics 14 (5) (2022)
Carlo Chiesa, Katarina Sjogreen-Gleisner, Stephan Walrand, Lidia Strigari, Glenn Flux, Jonathan Gear, Caroline Stokke, Pablo Minguez Gabina, Peter Bernhardt, Mark W Konijnenberg
EANM dosimetry committee series on standard operational procedures: a unified methodology for 99mTc-MAA pre- and 90Y peri-therapy dosimetry in liver radioembolization with 90Y microspheres. EJNMMI physics 8 (1) (2021)
Joey Roosen, Nienke J M Klaassen, Lovisa E L Westlund Gotby, Christiaan G Overduin, Marcel Verheij, Mark W Konijnenberg, Johannes Frank Wilhelmus Nijsen
To 1000 Gy and back again: a systematic review on dose-response evaluation in selective internal radiation therapy for primary and secondary liver cancer. European journal of nuclear medicine and molecular imaging 48 (12) (2021)
Christina P W Cox, Daniëlle M E van Assema, Frederik A Verburg, Tessa Brabander, Mark W Konijnenberg, Marcel Segbers
A dedicated paediatric [18F]FDG PET/CT dosage regimen. EJNMMI research 11 (1) (2021)